Verrica Pharmaceuticals Inc (VRCA)
8.16
+0.04
(+0.49%)
USD |
NASDAQ |
Jun 17, 16:00
8.15
-0.01
(-0.12%)
After-Hours: 20:00
Verrica Pharmaceuticals Accounts Receivable (Quarterly): 7.002M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.002M |
| December 31, 2023 | 4.248M |
| September 30, 2023 | 3.946M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.388M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2021
7.002M
Maximum
Mar 2024
2.226M
Average
0.388M
Median
Dec 2022
Accounts Receivable (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 194.10M |
| Macrogenics Inc | 7.219M |
| Aquestive Therapeutics Inc | 6.703M |
| Recursion Pharmaceuticals Inc | -- |
| Omega Therapeutics Inc | 0.00 |